Vaccination of Women with Metastatic Breast Cancer, Using a Costimulatory Gene (CD80)-Modified, HLA-A2-Matched, Allogeneic, Breast Cancer Cell Line: Clinical and Immunological Results-Reference-Cited by-同舟云学术

Vaccination of Women with Metastatic Breast Cancer, Using a Costimulatory Gene (CD80)-Modified, HLA-A2-Matched, Allogeneic, Breast Cancer Cell Line: Clinical and Immunological Results

Published:2003-07-20 Issue:11 Volume:14 Page:1117-1123
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Dols Annemieke¹,Smith John W.¹,Meijer Sybren L.¹,Fox Bernard A.²,Hu Hong-Ming¹,Walker Edwin¹,Rosenheim Sidney³,Moudgil Tarsem¹,Doran Teri¹,Wood William⁴,Seligman Mark⁵,Alvord W. Gregory⁶,Schoof Deric¹,Urba Walter J.¹

Affiliation:

1. Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, OR 97213

2. Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, OR 97213; Department of Biochemistry and Molecular Biology, Oregon Graduate Institute School of Science and Technology, and Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239

3. Department of Pathology, Providence Portland Medical Center, Portland, OR 97213

4. Department of Surgery, Providence Portland Medical Center, Portland, OR 97213

5. Oregon Hematology Oncology Associates, Providence Portland Medical Center, Portland, OR 97213

6. Computer and Statistical Services, Frederick Cancer Research and Development Center, Frederick, MD 21702

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/104303403322124828

Reference20 articles.

1. Phase I Trial of a B7-1 (CD80) Gene Modified Autologous Tumor Cell Vaccine in Combination With Systemic Interleukin-2 in Patients With Metastatic Renal Cell Carcinoma

2. Breast Tumor Cell Lines From Pleural Effusions2

3. Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2.

4. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Progress on Therapeutic Vaccines for Breast Cancer;Frontiers in Oncology;2022-06-06

2. Changing Landscape of Cancer Vaccines—Novel Proteomics Platform for New Antigen Compositions;International Journal of Molecular Sciences;2022-04-15

3. Breast Cancer Vaccines: Disappointing or Promising?;Frontiers in Immunology;2022-01-28

4. Emerging immunotherapeutic strategies for the treatment of breast cancer;Breast Cancer Research and Treatment;2021-10-30

5. Cancer Vaccines, Treatment of the Future: With Emphasis on HER2-Positive Breast Cancer;International Journal of Molecular Sciences;2021-01-14